EUVIMEDEUVIMED entdecken
Crossref

Chemotherapy-induced ovarian toxicity: Pathological mechanisms and fertility preservation strategies

Peng-Yu Yao, Hemaniswarri Dewi Dewadas, Yang Mooi Lim

Cancer Advances · 2026 · 9 · e26023

DOI: 10.53388/2026926023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Advances, 2026. Verfasst von Peng-Yu Yao und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer treatment has continuously improved in both concept and technology, yet current cancer therapies still confront numerous challenges. Chemotherapy remains the cornerstone of cancer treatment, but its non-selective nature leads to significant systemic toxicity. Among these side effects, Chemotherapy-induced ovarian toxicity (CIOT) remains as profound complication. This review aims to thoroughly analyze the pathological mechanisms underlying CIOT and summarize the existing clinical management strategies. CIOT is mediated by multiple intertwined pathological mechanisms, centrally involving the death of oocytes and granulosa cells. The main forms of cell death include apoptosis, ferroptosis, and pyroptosis. Furthermore, vascular damage, cellular senescence, inflammation, and endoplasmic reticulum stress (ERS) also contribute synergistically to ovarian damage. Fertility preservation and ovarian protection are the two fundamental treatment strategies. Fertility preservation encompasses three officially recognized clinical techniques: embryo cryopreservation, oocyte cryopreservation, and ovarian tissue cryopreservation. Gonadotropin-releasing hormone agonists (GnRHa) are used clinically for pharmacologic ovarian protection. Although the efficacy of GnRHa remains controversial, it is still utilized as a clinical option. Mesenchymal stem cells (MSCs) are promising for reversing chemotherapy-induced ovarian damage, yet they are hindered by donor heterogeneity and passage-related limitations. Additionally, traditional Chinese medicine (TCM) has been confirmed to effectively alleviate CIOT through multi-mechanistic approaches. Pathway-targeted drugs also remain as the focus of substantial research attention. A deep understanding of the diverse pathological mechanisms of CIOT is crucial for developing targeted protection strategies. The integrated application of established fertility preservation techniques and pharmacological interventions, including complementary and alternative medical therapies, is key to improving the long-term reproductive health and quality of life for female cancer patients.

Zitieren

APA

Yao, P., Dewadas, H. D., & Lim, Y. M. (2026). Chemotherapy-induced ovarian toxicity: Pathological mechanisms and fertility preservation strategies. Cancer Advances, 9(0), e26023. https://doi.org/10.53388/2026926023

Vancouver

Yao P, Dewadas HD, Lim YM. Chemotherapy-induced ovarian toxicity: Pathological mechanisms and fertility preservation strategies. Cancer Advances. 2026;9(0):e26023. doi:10.53388/2026926023

BibTeX
@article{Yao2026,
  author = {Yao, Peng-Yu and Dewadas, Hemaniswarri Dewi and Lim, Yang Mooi},
  title = {Chemotherapy-induced ovarian toxicity: Pathological mechanisms and fertility preservation strategies},
  journal = {Cancer Advances},
  year = {2026},
  volume = {9},
  number = {0},
  pages = {e26023},
  doi = {10.53388/2026926023}
}
Kostenlos starten →